Floatz logo

Srd-001

DMD-Associated Dilated Cardiomyopathy

Sardocor Corp.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the DMD-Associated Dilated Cardiomyopathy cohort.

Asset / SponsorPhaseRating
Empagliflozin
Sebastiano Lava
Phase 2CCC
Angiotensin-(1-7)
Constant Therapeutics LLC
Phase 2CCC

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →